{"title":"Design, synthesis, and biological evaluation of novel quinoline-based EGFR/HER-2 dual-target inhibitors as potential anti-tumor agents","link":"http://pubs.rsc.org/en/Content/ArticleLanding/2024/RA/D4RA06394E","date":null,"content":"<div><p><img src=\"/services/images/RSCpubs.ePlatform.Service.FreeContent.ImageService.svc/ImageService/image/GA?id=D4RA06394E\" /></p></div><div><i><b>RSC Adv.</b></i>, 2024, <b>14</b>,32978-32991<br /><b>DOI</b>: 10.1039/D4RA06394E, Paper</div><div><img alt=\"Open Access\" src=\"http://sod-a.rsc-cdn.org/pubs.rsc-uat.org/content/NewImages/open_access_blue.png\" /> Open Access</div><div><a href=\"http://creativecommons.org/licenses/by/3.0/\" target=\"_blank\"> <img src=\"http://sod-a.rsc-cdn.org/pubs.rsc-uat.org/content/NewImages/CCBY.png\" alt=\"Creative Commons Licence\" /></a>  This article is licensed under a <a href=\"http://creativecommons.org/licenses/by/3.0/\" target=\"_blank\">Creative Commons Attribution 3.0 Unported Licence.</a></div><div>Lamya H. Al-Wahaibi, Essmat M. El-Sheref, Hendawy N. Tawfeek, Hesham A. Abou-Zied, Safwat M. Rabea, Stefan Bräse, Bahaa G. M. Youssif<br />A series of new quinoline-based derivatives was designed and synthesised. The structures of the new compounds were validated by IR, NMR, and elemental analysis. The new compounds were evaluated as antiproliferative agents targeting EGFR, and HER2.<br />The content of this RSS Feed (c) The Royal Society of Chemistry</div>","author":"","siteTitle":"RSC - RSC Adv. latest articles","siteHash":"da3e282678330308414c63a405ade89dd3738fcce2936ca8a2fe3a6d7e967d99","entryHash":"4c22878bc0bac0cabb6fb67fdeb45187b5683860d02462df66078e56531338a9","category":"Environment"}